Union for International Cancer Control (UICC) shared a post on LinkedIn:
“People with cancer face up to 3 times higher rates of antimicrobial-resistant infections (The Lancet Oncology), making AMR a direct threat to cancer outcomes.
At the side event on Mobilising Action on AMR and NCDs at UNGA, a collaboration between the Norwegian Cancer Society, UICC, the Swedish Cancer Society, GARDP, and the Permanent Mission of Norway to the United Nations, experts stressed:
- The urgent need to integrate AMR into NCD care, especially cancer care
- Ensuring equitable access and filling R&D gaps
- The role of the NCD community in driving accelerated action
- The importance of civil society in a comprehensive AMR response
Find The Lancet Group review.”
Title: Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study
Authors: Vikas Gupta, Michael J. Satlin, Kalvin C. Yu, Yehoda Martei, Lillian Sung, Lars F. Westblade, Scott Howard, ChinEn Ai, Diane C. Flayhart
Read the Full Article on The Lancet Oncology
More posts featuring UICC.
